We serve Chemical Name:(5-Isopropoxypyridin-3-yl)boronic acid CAS:850991-41-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(5-Isopropoxypyridin-3-yl)boronic acid
CAS.NO:850991-41-2
Synonyms:(5-propan-2-yloxypyridin-3-yl)boronic acid
Molecular Formula:C8H12BNO3
Molecular Weight:180.99700
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:62.58000
Exact Mass:181.09100
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (5-propan-2-yloxypyridin-3-yl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(5-propan-2-yloxypyridin-3-yl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5-propan-2-yloxypyridin-3-yl)boronic acid Use and application,(5-propan-2-yloxypyridin-3-yl)boronic acid technical grade,usp/ep/jp grade.
Related News: Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves. (5-Isopropoxypyridin-3-yl)boronic acid manufacturer The United Kingdom, for instance, is now warning against all but essential travel to mainland China, and is advising against all travel to Hubei province, where the outbreak was first reported. (5-Isopropoxypyridin-3-yl)boronic acid supplier The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market. (5-Isopropoxypyridin-3-yl)boronic acid vendor The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. (5-Isopropoxypyridin-3-yl)boronic acid factory The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.
